Companies
- Companies
- Company details
Stanford University
Out-licensing
1D6 Mab Reacting with Human CD81: Excellent Western Reagent and Immunohistochemical Reagent More
21-25nt Capped Small Priming RNAs as Targets in Drug Discovery and Therapeutics More
4D Computed Tomography Adaptive Control Method and System for Reducing Motion Artefacts and Patient Dose More
4D Intensity Modulated Radiation Treatment Planning for Respiratory Motion Compensated Treatments More
A Gene Encoding a Red-Emitting Firefly Luciferase for use in Diagnostic Assays More
A Live Cell Fluorescent Mitosis Biosensor: Screen for Small Molecule and Genome Libraries for Effects of New or Existing Drugs on Cell Cycle More
A Method for Respiratory Audio-visual Bio-Feedback for Imaging and Radiotherapy Treatment More
A Method for the Treatment of Learning and Cognitive Disabilities in People with Down Syndrome and Dementia in Alzheimer's Disease More
A Monoclonal Antibody Specific for Mouse and Human B Cells More
A Monoclonal Antibody Specific for Mouse Granulocytes More
A Mouse Model and New Therapeutic Target for Psoriasis More
A Multiplex, Real-Time PCR Assay for the Rapid and Accurate Identification of S. lugdunensis More
A New Method for Microbial Biofilm Destruction and Interfering with Cellular Microbial Physiology: Identify Inhibitors of c-di-GMP Signalling as a New Class of Antibiotics More
A Novel Protein and Gene Expressed by Human T Cells and Monocytes: Alloreaction-Associated Antigen (ARAg) More
A Novel Synthesis of 2'-Deoxy-2'-[18F]fluoro-9-ß-D-arabino-furanosylguanine ([18F]F-AraG): Imaging T Cell Activation with PET More
A Novel Two-colour Fab Labelling Method for Autoantigen Microarrays More
A Novel Variant of the EGFR Protein to Identify and Target Cancer Stem Cells (CSCs) More
A Tumour Visualization/Detection Method using Magnetic Resonance Imaging (MRI) and Magnetotactic Bacteria as an MRI Contrast Agent that can Enhance Positive and Negative Contrast More
Accelerated Tomographic Image Reconstruction Algorithms on Graphics Processing Units (GPU) More
ACE Inhibitors for the Treatment of Autoimmune Disease eg, Multiple Sclerosis More
An Oral Enzyme Supplement for Celiac Sprue Patients with Inadequate Response to a Gluten-Free Diet More
Anaerobe Targeted Enzyme-Mediated Prodrug Therapy: A Tumour-Selective Therapy More
Angiogenesis Inhibition by Secreted Protein Egfl7 More
Anti-Viral Activity of Leukaemia Inhibitory Factor for the Treatment of Influenza More
Antigen Presenting Vehicle for the Treatment and Prevention of Herpes Infection More
Antimicrobial Activity of Granulysin: Potent Cytolytic Molecule with a Novel Mechanism of Action and Target Specificity More
Apoptolidin Analogue as an Improved Anti-Cancer Agent and Related Screening Methods More
Assay for Influenza Viruses, Including H5N1: Point-of-Care Diagnostics More
Basal Markers in Breast Cancer: Methods of Classifying, Diagnosing, Stratifying and Treating Cancer Patients and their Tumours More
Biomarker Detection using Functionalized Microfluidic Channels More
Biomarkers for Inflammatory and Autoimmune Diseases including Rheumatoid Arthritis and MS More
Blood Assay for Diagnosing Acute and Chronic Pancreatitis More
Blood Biomarkers of Healthy Aging for the Detection and Treatment of Age-Related Disorders More
Botulism Toxin Induced Sympathectomy: A Novel Method for Chronic Pain Relief More
Bryostatin Analogues for Cancer, Bolstering Immunity and Multidrug Resistance More
Carbon Nanotubes as Molecular Transporters and Carriers for Drug, Gene Therapy and Protein Delivery More
Cell and Gene Therapy for the Treatment of Various Autoimmune Diseases More
Cell-based Muscle Regeneration and Drug Screening of Myogenic Agents More
Characterization of the Major Surface Antigen Gene of Toxoplasma: Use in Genetic Engineering, Vaccine Development and Disease Diagnosis More
Chemokine-like receptor-1 (CMKLR1) as a Therapeutic Target for the Treatment of Multiple Sclerosis More
Clasp-1 Mediates Lymphocyte Communication: Insight into Cell-cell Interactions in the Immune System More
Class 1-HLA Peptides and their Immunomodulatory Potential More
Compositions and Methods for Inhibiting Squamous Cell Carcinoma More
Compositions and Methods Using Variant Tat Polypeptides: HIV Vaccine Development, HIV Drug Screening and Diagnostics More
Coupling of Excitation and Neurogenesis in Neural Stem/progenitor Cells More
Development of a Novel Drug Delivery Stent Platform More
Development of a Novel Peptide Vaccine Strategy: Vaccination with Peptide Mixtures More
Development of a Novel Stroke Therapeutic: Misoprostol, a PGE2 Receptor Agonist, Protects in Cerebral Ischemia More
Development of a Novel Uranium Biosensor More
Development of a Self-Assembling, Biocompatible Hydrogel for Cell and Drug Encapsulation More
Development of Compounds for Circadian Hormonal Phase Shifting: Treating Jet Lag, Shift Work and Circadian Rhythm Disorder More
Development of Nonpolar Thymidine Mimics: Potential Nucleoside Drugs in Antiviral, Anti-Tumour and Antibacterial Applications More
Development of Novel Antisense Compounds to Akt-3: Towards the Modulation of Akt-3 expression in Akt-3 Implicated Cancers More
Development of Small Molecule Drugs with TGFbeta Signalling Activity More
Development of Viral Vectors Useful in Induction of Humoral or Cellular Immunity More
Discovery of ANK: a Novel Gene Controlling Mineral Deposition and Susceptibility to Arthritis More
Discovery of ER Calcium Sensor, which Controls Ca2+ Influx into Cells More
Discovery of Regulators of Cellular Ca2+ Concentration More
DNA-Encoded Combinatorial Chemistry for Drug Discovery More
DNA-Templated Combinatorial Library Device More
Elucidation of a Novel CMV Viral Protein: Treatment for Human Cytomegalovirus More
Elucidation of a Novel Host Cell Target For Inhibiting Viruses Like HCV More
Elucidation of an Early Diagnostic Marker of Rheumatological Diseases More
Elucidation of Anti-Angiogenic Treatment Responsive Peptides More
Elucidation of Biomarkers of Human Aging More
Elucidation of BOK: A New Member of the Bcl-2 Gene Family More
Elucidation of Diagnostic Markers and Targets in Human Heart Failure More
Elucidation of Nicotinamide Analogues as Radiosensitizers for Hypoxic Tumour Cells More
Elucidation of the Crystal Structure of the Beta2 Adrenoreceptor More
Encapsulated Nanoparticles for Target Specific Drug Delivery More
Endothelial Molecules and the Control of Leukocyte Extravasation More
Epidermal Growth Factor Mutants for Improved Epidermal and Epithelial Wound Healing More
Implantable or Insertable Human Fibrin Gel for Treatment of End-Stage Liver Diseases More
Improved Enzymes for Reductive Prodrug Cancer Chemotherapy More
Inflammatory Blockade for Restoring Neurogenesis More
Lung Progenitor Cells for Cellular Therapy of Lung Injuries More
Method for Predicting Genes Involved in Drug Response: More Reliable for Finding Pharmacogenes More
Methods for Diagnosis and Treatment of Human Autoimmune Diseases by Multiplex Determination of Autoantibody Specificities to Lipids More
Methods for Evaluating the Activity of Candidate Agents: Provides Insights into the Complex Interactions of Biochemical Markers Mediating Pain and Inflammation More
Methods to Detect and Treat Insulin Resistance, a Disorder Modulated by DDAH More
Methods to Improve Survival from Heart Failure in Chronic Hypertension and to Prevent Arterial Stenosis More
Minicircle DNA for Gene Delivery More
Modulation of Antibiotic Sensitivity of Bacteria by Manipulation of Bacterial Defence Mechanisms such as SOS Response More
Mouse Model for Hypertension and for Drug Screening of Antihypertensive Drugs More
Mouse Model for Progressive Myoclonus Epilepsy (EPM1) More
MreB, a Novel Target to Inhibit Bacterial Growth: Development of Novel Antibiotic Drugs Against the Bacterial Cytoskeleton Protein MreB More
Multipotent Neural Stem Cells Derived from Human Embryonic Stem Cells: Cell Therapy of Neurological Disorders More
New Light Control Mechanism (NpHR) that Inhibits Neural Activity More
New Pharmacological Targets and Diagnostic Markers in Heart Failure More
NF-AT Translocation as a Site of Therapeutic Intervention for Modulation of the Immune Response More
Non-Hormonal Method of Contraception using Type III Phosphodiesterase Inhibitors More
Novel Antimicrobial Peptides: Granulysin Derivatives that Exhibit High Activity Towards Microbes with Little or No Effect on Mammalian Cells More
Novel Diagnostic and Therapeutic Strategies in Lymphoedema More
Novel Endothelial Adhesion Molecule for Monocytes: Diagnosis and Therapy of Inflammation More
Novel Kinase Inhibitors for the Treatment of Various Diseases and Disorders More
Novel Mechanism of Immune Evasion as Potential Target for Antiviral Drugs More
Novel ShRNA Gene Therapy for Treatment of Ischemic Heart Disease: Activation of a Series of Genes Involved in Angiogenesis More
Optical Tissue Interface: Electrode-Based Modulation Therapies for Treating Diseases of the Heart, Brain and Muscle More
Peptides for the Treatment of Hepatitis C Virus Infections More
Pharmacological inhibition of NS4B's Nucleotide Binding Motif to suppress Hepatitis C viral replication and to decrease the occurrence of associated Hepatocellular Carcinoma More
Plasmid DNA Vectors that Integrate into Host Chromosomal DNA in vivo: Stable Gene Transfer for Biological Studies and Gene Therapy More
Predicting Anticancer Treatment Toxicity by Means of Transcriptional Profiling More
Protection from Ischemic Damage: Activation of Mitochondrial Dehydrogenase-2 More
RabGEF1 (Rin2, Rabex-5): A Novel Regulator of Ras-mediated and Endocytosis-Coupled Signalling and Functional Activation More
Recombinase-Mediated Site Specific Integration ("Wildtype" Recombinases): Construction of Transgenic Animals and Plants More
Relaxin Activates LGR7 and LGR8: Induction or Prevention of Labour More
Releasable Drug(probe)-Molecular Transporter Conjugates: Systems for Enabling or Enhancing Uptake of Drugs and Probes into Cells and Tissue More
Retinal Prosthesis based on Photomechanical Deflectors and Tactile Sensory Cells: Treatment of AMD and Retinitis Pigmentosa More
Robust Factor IX Minigene Expression Cassette: Gene Therapy for Inserting Genes that Require Liver-specific Expression More
Selenite as a Tumour Selective Chemotherapeutic and Radiosensitizing Agent for the Treatment of Androgen Dependent and Hormone Refractory Prostate Cancer More
SIRT6:NF-kappaB Interaction in Ageing and Inflammatory Diseases: Novel Drug Target More
Targeting Endocannabinoid Signalling for the Treatment of Parkinson's Disease and other Brain Disorders of the Striatum More
The Therapeutic use of Tolerogenic Dendritic Cells in Transplantation Tolerance and Inflammatory Diseases More
Treatment of Cancer using Apoptolidin Analogues, Derivatives and Formulations More
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
May 2009 - 89 pages - $695
Nov 2010 - 180 pages - $600
Jan 2012 - 29 pages - $250
Jul 2010 - 103 pages - $750
Mar 2011 - 31 pages - $1,000
Mar 2011 - 48 pages - $1,000
May 2011 - 49 pages - $1,000
Mar 2011 - 36 pages - $1,000
May 2011 - 55 pages - $1,000
Contact details
Head office
Stanford University
Office of Technology Licensing 1705 El Camino Real
Palo Alto
94306-1106
California (USA)
Office of Technology Licensing 1705 El Camino Real
Palo Alto
94306-1106
California (USA)
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us